latest news releases from the newsroom
Epigenomics DNA Methylation Test Successfully Detects Colorectal Cancer in Blood
BERLIN, Germany and SEATTLE, Dec. 19, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today positive results of a series of large clinical studies, demonstrating that its molecular diagnostic test developed in collaboration with Roche Diagnostics was able to detect colorectal cancer from a standard, non-invasive blood draw. Epigenomics believes that this diagnostic, which works by interpreting changes in DNA methylation, has the potential to support large-scale, general population colorectal cancer screening since early detection of colorectal cancer significantly improves treatment outcome. The test targets asymptomatic men and women over the age of 50 who are recommended to take an early detection test for colorectal cancer on a regular basis.
Komax Holding AG
Komax Group: Another major order
LUCERNE, Switzerland, Dec. 19, 2005 (PRIMEZONE) -- Ismeca Automation, a member of the Komax Group, announced that it has landed another major order worth CHF 15 million. The customer is a world-leading computer and electronics manufacturer from the United States.
Izard Nobel LLP
Schatz & Nobel, P.C. Announces Class Action Lawsuit against Diebold Inc. and the Investigation of Diebold, Inc. 401k Plans -- DBD
HARTFORD, Conn., Dec. 16, 2005 (PRIMEZONE) -- The law firm of Schatz & Nobel, P.C., which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Eastern District of Ohio on behalf of all persons who purchased the common stock of Diebold, Inc. (NYSE:DBD) ("Diebold") between October 22, 2003 and September 20, 2005 (the "Class Period").
Cubic Energy, Inc.
Cubic Energy, Inc. Announces Funding of Initial $2 Million through Private Placement
DALLAS, Dec. 16, 2005 (PRIMEZONE) -- Cubic Energy, Inc. (OTCBB:QBIK) ("Cubic" or the "Company") announced today that it closed on $2 Million through an equity transaction, whereby the Company issued 2,500,000 common shares at a price of $0.80/share, and issued warrants, with a five year expiration period, for the purchase of 1,000,000 Company common shares, at an exercise price of $1.00/share.
Parker Waichman Alonso LLP
Parker & Waichman, LLP Files Suit Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of Victim of Ortho Evra Birth Control Patch
NEW YORK, Dec. 16, 2005 (PRIMEZONE) -- Parker & Waichman, LLP (http://www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 19-year-old woman who suffered pulmonary embolism and deep venous thrombosis (DVT) after using the Ortho Evra contraceptive patch for 15 months. In July 2005, the plaintiff began experiencing a fluttering feeling in her chest followed by pain and shortness of breath. On July 7, 2005, the plaintiff was taken to the emergency room at Campbell Health System in Weatherford, Texas after experiencing shortness of breath and sharp discomfort in her mid-chest area. A CT Scan was performed which revealed pulmonary embolism obstructing nearly all of the right pulmonary artery and apparent pulmonary infarction in the right lower lobe. A Doppler venogram was also performed which revealed deep venous thrombosis (DVT) in the left common femoral and superficial femoral veins. As a result, the plaintiff was admitted to the hospital for Heparin and Coumadin (anticoagulant) therapy. The plaintiff will likely undergo prolonged treatment with these medications, which may be necessary for the remainder of her life. The suit was filed in the United States District Court for the District of New Jersey in Newark, New Jersey. For more information on Ortho Evra please visit http://www.orthopatchlawsuit.com or http://www.yourlawyer.com.
Tyche Energy Shareholders Elect Jean Claude Bonhomme to Serve as Chairman
TORONTO, Dec. 16, 2005 (PRIMEZONE) -- Tyche Energy, Inc., a subsidiary company of Biogenerics Limited (Pink Sheets:BIGN), announced today that effective immediately, Jean Claude Bonhomme will serve as Tyche Energy's Chairman of the Board. Mr. Bonhomme, presently Tyche's Executive Vice President, was elected to the position at the Company's recently held annual shareholders meeting.
Aquila Agrees to Sell Two Illinois Power Plants to AmerenUE
KANSAS CITY, Mo., Dec. 16, 2005 (PRIMEZONE) -- Aquila, Inc. (NYSE:ILA) today announced that it has reached an agreement to sell two peaking power generation facilities to Union Electric Company (AmerenUE) for a total purchase price of $175 million. Aquila expects to record a pre-tax impairment charge of approximately $160 million, or approximately $100 million after tax, on the sale of the power plants.